Everolimus

calcineurin binding protein 1 ; Homo sapiens







67 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
51 21334736 Everolimus-based, calcineurin-inhibitor-free regimen in recipients of de-novo kidney transplants: an open-label, randomised, controlled trial. 2011 Mar 5 3
52 21478817 Prospective study of everolimus with calcineurin inhibitor-free immunosuppression in maintenance heart transplant patients: results at 2 years. 2011 May 27 5
53 21693288 Calcineurin inhibitor-free immunosuppression using everolimus (Certican) after heart transplantation: 2 years' follow-up from the University Hospital Münster. 2011 Jun 5
54 21911148 A retrospective 12-month study of conversion to everolimus in lung transplant recipients. 2011 Sep 1
55 20050127 Reduction of cyclosporine following the introduction of everolimus in maintenance heart transplant recipients: a pilot study. 2010 Jan 1
56 20061999 Everolimus with reduced calcineurin inhibitor in thoracic transplant recipients with renal dysfunction: a multicenter, randomized trial. 2010 Apr 15 5
57 21030905 Two-year outcomes in thoracic transplant recipients after conversion to everolimus with reduced calcineurin inhibitor within a multicenter, open-label, randomized trial. 2010 Dec 27 2
58 19542890 Renal-sparing strategies in cardiac transplantation. 2009 Oct 1
59 19715854 Conversion to everolimus in kidney transplant recipients with decreased renal function. 2009 Jul-Aug 1
60 18223473 Everolimus exposure in cardiac transplant recipients is influenced by concomitant calcineurin inhibitor. 2008 Feb 1
61 18793527 Conversion from sirolimus to everolimus in maintenance renal transplant recipients within a calcineurin inhibitor-free regimen: results of a 6-month pilot study. 2008 Aug 1
62 17346627 Calcineurin inhibitor-free immunosuppression using everolimus (Certican) in maintenance heart transplant recipients: 6 months' follow-up. 2007 Mar 5
63 16815852 Everolimus in clinical practice--renal transplantation. 2006 Jul 1
64 17097956 Conversion to everolimus in kidney transplant recipients: a safe and simple procedure. 2006 Oct 1
65 15880017 Reduction in calcineurin inhibitor exposure and maintenance of effective immunosuppression: clinical experience with everolimus (Certican). 2005 May 15 2
66 15880021 Clinical experience with everolimus (Certican): optimizing dose and tolerability. 2005 May 15 2
67 15093807 Optimizing the immunosuppressive regimen in heart transplantation. 2004 May 2